BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ni H, Qin H, Sun C, Liu Y, Ruan G, Guo Q, Xi T, Xing Y, Zheng L. MiR-375 reduces the stemness of gastric cancer cells through triggering ferroptosis. Stem Cell Res Ther 2021;12:325. [PMID: 34090492 DOI: 10.1186/s13287-021-02394-7] [Cited by in F6Publishing: 23] [Reference Citation Analysis]
Number Citing Articles
1 Yang Y, Meng W, Wang Z. The origin of gastric cancer stem cells and their effects on gastric cancer: Novel therapeutic targets for gastric cancer. Front Oncol 2022;12:960539. [DOI: 10.3389/fonc.2022.960539] [Reference Citation Analysis]
2 He J, Wang X, Chen K, Zhang M, Wang J. The amino acid transporter SLC7A11-mediated crosstalk implicated in cancer therapy and the tumor microenvironment. Biochem Pharmacol 2022;205:115241. [PMID: 36084707 DOI: 10.1016/j.bcp.2022.115241] [Reference Citation Analysis]
3 Li F, Long H, Zhou Z, Luo H, Xu S, Gao L. System Xc−/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy. Front Pharmacol 2022;13:910292. [DOI: 10.3389/fphar.2022.910292] [Reference Citation Analysis]
4 Lu L, Chen B, Xu Y, Zhang X, Jin L, Qian H, Wang Y, Liang ZF. Role of ferroptosis and ferroptosis-related non-coding RNAs in the occurrence and development of gastric cancer. Front Pharmacol 2022;13:902302. [DOI: 10.3389/fphar.2022.902302] [Reference Citation Analysis]
5 Abedi M, Rahgozar S. Puzzling Out Iron Complications in Cancer Drug Resistance. Crit Rev Oncol Hematol 2022;:103772. [PMID: 35914667 DOI: 10.1016/j.critrevonc.2022.103772] [Reference Citation Analysis]
6 Xiao J, Zheng L, Liu J. Comprehensive Analysis of the Aberrance and Functional Significance of Ferroptosis in Gastric Cancer. Front Pharmacol 2022;13:919490. [DOI: 10.3389/fphar.2022.919490] [Reference Citation Analysis]
7 Gu R, Xia Y, Li P, Zou D, Lu K, Ren L, Zhang H, Sun Z. Ferroptosis and its Role in Gastric Cancer. Front Cell Dev Biol 2022;10:860344. [DOI: 10.3389/fcell.2022.860344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Li S, Lu Z, Sun R, Guo S, Gao F, Cao B, Aa J. The Role of SLC7A11 in Cancer: Friend or Foe? Cancers 2022;14:3059. [DOI: 10.3390/cancers14133059] [Reference Citation Analysis]
9 Pehlevan Özel H, Dinç T, Tiryaki R, Keşküş A, Konu Ö, Kayilioğlu S, Coşkun F. Targeted microRNA Profiling in Gastric Cancer with Clinical Assessement. Balkan Journal of Medical Genetics 2021;24:55-64. [DOI: 10.2478/bjmg-2021-0022] [Reference Citation Analysis]
10 Ju F, Atyah MM, Horstmann N, Gul S, Vago R, Bruns CJ, Zhao Y, Dong QZ, Ren N. Characteristics of the cancer stem cell niche and therapeutic strategies. Stem Cell Res Ther 2022;13:233. [PMID: 35659296 DOI: 10.1186/s13287-022-02904-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Balihodzic A, Prinz F, Dengler MA, Calin GA, Jost PJ, Pichler M. Non-coding RNAs and ferroptosis: potential implications for cancer therapy. Cell Death Differ 2022;29:1094-106. [PMID: 35422492 DOI: 10.1038/s41418-022-00998-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Yu R, Zhou Y, Shi S, Wang X, Huang S, Ren Y. Icariside II induces ferroptosis in renal cell carcinoma cells by regulating the miR-324-3p/GPX4 axis. Phytomedicine 2022. [DOI: 10.1016/j.phymed.2022.154182] [Reference Citation Analysis]
13 Valashedi MR, Bamshad C, Najafi-Ghalehlou N, Nikoo A, Tomita K, Kuwahara Y, Sato T, Roushandeh AM, Roudkenar MH. Non-coding RNAs in ferroptotic cancer cell death pathway: meet the new masters. Hum Cell 2022. [PMID: 35415781 DOI: 10.1007/s13577-022-00699-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Liu Y, Zhang H, Han X, Xing X, M.a. B. Bioinformatics Methods Reveal the Biomarkers and the miRNA-mRNA Network in Hepatocellular Carcinoma. Journal of Healthcare Engineering 2022;2022:1-8. [DOI: 10.1155/2022/9963096] [Reference Citation Analysis]
15 Jyotsana N, Ta KT, DelGiorno KE. The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer. Front Oncol 2022;12:858462. [PMID: 35280777 DOI: 10.3389/fonc.2022.858462] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
16 Rahman MA, Ahmed KR, Rahman MH, Park MN, Kim B. Potential Therapeutic Action of Autophagy in Gastric Cancer Managements: Novel Treatment Strategies and Pharmacological Interventions. Front Pharmacol 2022;12:813703. [DOI: 10.3389/fphar.2021.813703] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Fang W, Shi C, Wang Y, Song J, Zhang L. microRNA-128-3p inhibits CD4+ regulatory T cells enrichment by targeting interleukin 16 in gastric cancer. Bioengineered 2022;13:1025-38. [PMID: 34968167 DOI: 10.1080/21655979.2021.2017566] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Xiao S, Liu X, Yuan L, Wang F. A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Therapeutic Response of Gastric Cancer. Front Cell Dev Biol 2021;9:736682. [PMID: 34926441 DOI: 10.3389/fcell.2021.736682] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
19 Guo Q, Li L, Hou S, Yuan Z, Li C, Zhang W, Zheng L, Li X. The Role of Iron in Cancer Progression. Front Oncol 2021;11:778492. [PMID: 34858857 DOI: 10.3389/fonc.2021.778492] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
20 Xiao X, Rui B, Rui H, Ju M, Hongtao L. MEOX1 suppresses the progression of lung cancer cells by inhibiting the cell-cycle checkpoint gene CCNB1. Environ Toxicol 2021. [PMID: 34837450 DOI: 10.1002/tox.23416] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
21 Chen D, Ping S, Xu Y, Wang M, Jiang X, Xiong L, Zhang L, Yu H, Xiong Z. Non-Coding RNAs in Gastric Cancer: From Malignant Hallmarks to Clinical Applications. Front Cell Dev Biol 2021;9:732036. [PMID: 34805143 DOI: 10.3389/fcell.2021.732036] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
22 Chen X, Zhu Z, Li X, Yao X, Luo L. The Ferroptosis-Related Noncoding RNA Signature as a Novel Prognostic Biomarker in the Tumor Microenvironment, Immunotherapy, and Drug Screening of Gastric Adenocarcinoma. Front Oncol 2021;11:778557. [PMID: 34790582 DOI: 10.3389/fonc.2021.778557] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
23 Xu C, Liu Z, Xiao J. Ferroptosis: A Double-Edged Sword in Gastrointestinal Disease. Int J Mol Sci 2021;22:12403. [PMID: 34830285 DOI: 10.3390/ijms222212403] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
24 Chen ZQ, Yuan T, Jiang H, Yang YY, Wang L, Fu RM, Luo SQ, Zhang T, Wu ZY, Wen KM. MicroRNA‑8063 targets heterogeneous nuclear ribonucleoprotein AB to inhibit the self‑renewal of colorectal cancer stem cells via the Wnt/β‑catenin pathway. Oncol Rep 2021;46:219. [PMID: 34396427 DOI: 10.3892/or.2021.8170] [Cited by in F6Publishing: 1] [Reference Citation Analysis]